Trial Profile
Drug-drug interactions in patients with castration-resistant prostate cancer undergoing abiraterone therapy.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Aug 2015
Price :
$35
*
At a glance
- Drugs Abiraterone acetate (Primary)
- Indications Prostate cancer
- Focus Adverse reactions
- 25 Aug 2015 New trial record